Iovance Biotherapeutics, Inc. (LON: 0JDK)
London
· Delayed Price · Currency is GBP · Price in USD
5.95
-0.02 (-0.29%)
At close: Jan 22, 2025
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 557 employees as of December 30, 2023. The number of employees increased by 54 or 10.74% compared to the previous year.
Employees
557
Change (1Y)
54
Growth (1Y)
10.74%
Revenue / Employee
121.70K GBP
Profits / Employee
-549.19K GBP
Market Cap
1.48B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Iovance Biotherapeutics News
- 5 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 12 days ago - Iovance Biotherapeutics Shares Are Falling Today: What's Going On? - Benzinga
- 14 days ago - Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market - CNBC
- 20 days ago - Iovance Biotherapeutics (IOVA) Surges on Positive Analyst Outlook - GuruFocus
- 20 days ago - Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today - The Motley Fool
- 4 weeks ago - Iovance Biotherapeutics Inc (IOVA) Announces Inducement Stock Options for New Employees - GuruFocus
- 4 weeks ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire